Government unveils plan to stabilise medicine prices

Dr Zafar Mirza says govt to present new policy; revamp hospitals in Islamabad


Zulfiqar Baig May 17, 2019
PHOTO: REUTERS

ISLAMABAD: The government has brought down the hike in prices of medicines from 300% to 75%, said Special Assistant to PM (SAPM) on National Health Services, Regulations and Coordination Dr Zafar Mirza on Thursday.

The surge in prices had occurred due to rise in dollar rates, he said addressing a press conference. Prices of some 889 drugs were revised under hardship cases. He said when he took the office, the prices of 464 drugs had been increased which had distressed the public however the prime minister immediately ordered to revise them to their previous prices within three days.

He further said that in light of orders of the prime minister, the mapping process of hospitals and dispensaries in the federal capital will begin soon.

According to the plan, the data of patients visiting the hospitals and dispensaries would be collected which would then be utilised for converting the hospitals to an international standard.

Mirza said he had accepted the ministry as a challenge.

He said that the government has decided to present a new national medicines policy to regulate the pharmaceutical industry and controlling the drugs prices.

Addressing a press conference here, the minister said that the new policy is being made in consultation with all stakeholders to ensure availability of life saving drugs and keeping prices of all drugs in reach of a lay man.

He said that the new medicines policy will also cover the aspect of rules and regulations to streamline the production of medicines and maintaining its quality as per international standard.

Cabinet takes steps to cut drugs prices

 

Dr Mirza said that under this policy, the government will also get inputs from the stakeholders for announcing more incentives for pharmaceutical industry in order to convince those producing standard medicines in the market.

He said that the new policy will also manage the issues related with the sale of medicines without prescription of medical practitioners and open sale of unauthorised medicines to customers.

He said that the government has decided to make Drug Regulatory Authority of Pakistan (DRAP) a model regulatory authority with introduction of new reforms in order to facilitate the people and addressing the issues of quality and pricing of drugs.

The minister said that quick response of government to normalise the prices of medicines will have relief impact of Rs10 billion on patients. The government has decided to utilise this amount on further serving the ailing population, he added.

He said that the government will ensure availability of essential medicines and life-saving drugs in the market on normal rates. He added around 50 to 60 such medicines are still unavailable in the market and the pharmaceutical industry has been asked to manage these medicines for patients.

He said that meetings will be held with representatives of pharmaceutical industry in Lahore and Karachi to get assurance from them regarding production of these unavailable life-saving drugs in the markets.

He said that the pharmaceutical industry has assured that they will manage the increased prices of medicines on new batches.

He said that the government was also working on assessment of standard of medicines being produced by the local pharmaceutical industry to maintain its quality. He added the government is also vigilant on sale of illegal, spurious, unregistered and fake medicines in the market.

Drug court to try firms refusing to cut prices

The minister said that through an SRO issued on December 31, the government had fixed the maximum retail price of 889 medicines. He added the prices of 395 medicines were decreased while prices of 464 medicines were increased.

He said that unfortunately the industry had increased the prices of some medicines. He said that after detailed meetings with pharmaceutical industry, it was also mutually decided that the pharmaceutical industry will decrease the prices of 464 medicines which they had increased after government's Statutory Regulatory Order (SRO).

Dr Zafar also announced to withdraw the nine per cent price increase order of the government on medicines. He said that the government has decided to move to drugs courts for recovery from pharmaceutical companies on collecting extra money from consumers on selling 395 medicines on high prices since January this year.

He added this saving after recovery from the industry will be submitted in fund of Pakistan Baitul Mal to facilitate citizens who are unable to afford medicines.

He said that the decision was made keeping in view the concerns of people about increasing prices of medicines. He said that this is short term relief while the ministry has started working on long term relief for people.

The minister said that the ministry of national health services in line with the vision of Prime Minister Imran Khan will revamp the entire health system of the federal capital and make it a model health city of the country.

He added all major hospitals of federal capital are being revamped to have quality medical care services for population of Islamabad Capital Territory. He added the government will also improve the quality of 53 dispensaries working in the federal capital.

He said that the government has completed mapping of private health facilities in the federal capital while in next phase it will start mapping of public sector health facilities. He added the main objective behind this exercise is to complete the requirements as per demand and improving the quality of service delivery system for patients.

He said that keeping in view the existing burden of patients on Pakistan Institute of Medical Sciences (PIMS), the government has planned to construct new hospitals besides improving the health centres to share the patients' burden.

Published in The Express Tribune, May 17th, 2019.

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ